Management of hemopoietic neoplasias during pregnancy

PAYDAŞ S.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, cilt.104, ss.52-64, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 104
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.critrevonc.2016.05.006
  • Dergi Adı: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.52-64
  • Anahtar Kelimeler: Hemopoietic neoplasia, Pregnancy, Chemotherapy, Radiation therapy, Supportive care, Leukemia, Lymphoma, Myeloproliferative neoplasia, Fertility preservation, CHRONIC MYELOID-LEUKEMIA, CHRONIC MYELOGENOUS LEUKEMIA, NON-HODGKINS-LYMPHOMA, ESSENTIAL THROMBOCYTHEMIA, MULTIPLE-MYELOMA, INTERFERON-ALPHA, HEMATOLOGICAL MALIGNANCIES, CHEMOTHERAPEUTIC-AGENTS, ANTINEOPLASTIC AGENTS, INDUCTION THERAPY
  • Çukurova Üniversitesi Adresli: Evet

Özet

Hemopoietic neoplasias are unique cancers generally affecting bone marrow, and requires a special attention for disease control and also their complications. When these neoplastic disorders accompany to pregnancy there are many risks both for mother and foetus. Diagnostic difficulties due to the limited use of imaging modalities is essential in pregnant women. On the other hand suboptimal using of the antineoplastic drugs and their higher toxicity in mother and foetus must be considered in the management of these neoplastic disorders. Due to the lack of therapeutic guidelines in these cases, team approach is essential and therapy requires to the use the art of medicine. (C) 2016 Elsevier Ireland Ltd. All rights reserved.